Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
PaperCitations, authors & open-access status
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,336 citations, 2021 year and green oa status.
1,336
Citations
2021
Year
green
OA Status